TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group
Final published version, 618 KB, PDF document
Original language | English |
---|---|
Article number | 360 |
Journal | B M C Cancer |
Volume | 14 |
Number of pages | 14 |
ISSN | 1471-2407 |
DOIs | |
Publication status | Published - 2014 |
- TIMP-1, Gemcitabine, Docetaxel, Breast cancer, Prediction, Prognosis
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 125791294